| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5466446 | STIEFEL | Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
Feb, 2014
(10 years ago) | |
Duac is owned by Stiefel.
Duac contains Benzoyl Peroxide; Clindamycin Phosphate.
Duac has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Duac are:
- US5466446
Duac was authorised for market use on 26 August, 2002.
Duac is available in gel;topical dosage forms.
The generics of Duac are possible to be released after 16 February, 2014.
Drugs and Companies using BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE ingredient
Market Authorisation Date: 26 August, 2002
Treatment: NA
Dosage: GEL;TOPICAL
How can I launch a generic of DUAC before it's drug patent expiration?
More Information on Dosage
DUAC family patents
